Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Novartis' Rydapt approval ends long AML therapy drought

Novartis' Rydapt approval ends long AML therapy drought Daiichi Sankyo's quizartinib - acquired along with Ambit Biosciences' for $410m in 2014 - and Arog Pharma's crenolanib are both in phase III testing in FLT3-positive AML.

Japanese pharma pulls no punches with post-Brexit UK

Japanese pharma pulls no punches with post-Brexit UK The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

Deal Watch March 2017

Deal Watch March 2017 Resarci out-licensed ACAT-1 to Xynomic, as detailed above, and Daiichi Sankyo paid $4m upfront, committed $8m in research funding and further research, development and commercialisation milestone payments for the ... 20. Heptares/ Sosei Group. Daiichi

Hookipa Biotech appoints new global head of research and development

Hookipa Biotech appoints new global head of research and development Dr Igor Matushansky joins the firm from Daiichi Sankyo. Hookipa Biotech has appointed Dr Igor Matushansky as its global head, research and development in a role that focuses on strategic priorities. ... Previously global head of translational development

Xarelto beats aspirin for recurrent blood clots

Xarelto beats aspirin for recurrent blood clots rival NOAC Eliquis (apixaban) from Pfizer and Bristol-Myers Squibb (BMS) with 42.5%, well ahead of third place Pradaxa (dabigatran) from Boehringer Ingelheim and Daiichi Sankyo's new entrant Savaysa

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics